Variant report

Variant	nsv522091
Chromosome Location	chr4:69932587-69988378
allele	n/a
Outlinks	Ensembl UCSC

Chromatin state
Related regulatory elements
Target genes
Other information

No.	Transcrition factor	Chromosome Location	Cell Line	Cell type	Cell Stage	Matched TF binding sites
1	ARID3A	chr4:69968302-69968701	HepG2	liver:	n/a	n/a
2	ARID3A	chr4:69964127-69964803	HepG2	liver:	n/a	n/a
3	ARID3A	chr4:69960997-69962638	HepG2	liver:	n/a	n/a
4	ARID3A	chr4:69981638-69981898	HepG2	liver:	n/a	n/a
5	ATF1	chr4:69932559-69932881	K562	blood:	n/a	n/a
6	ATF3	chr4:69961043-69961523	A549	lung:	n/a	n/a
7	ATF3	chr4:69961016-69961540	A549	lung:	n/a	n/a
8	BATF	chr4:69988190-69988541	GM12878	blood:	n/a	n/a
9	BATF	chr4:69958781-69959019	GM12878	blood:	n/a	n/a
10	BATF	chr4:69988219-69988511	GM12878	blood:	n/a	n/a
11	BCL3	chr4:69961801-69962281	A549	lung:	n/a	n/a
12	BCL3	chr4:69960907-69962340	A549	lung:	n/a	n/a
13	BHLHE40	chr4:69959220-69959407	GM12878	blood:	n/a	n/a
14	BHLHE40	chr4:69984332-69984392	GM12878	blood:	n/a	n/a
15	BHLHE40	chr4:69932682-69932824	K562	blood:	n/a	n/a
16	CEBPB	chr4:69964189-69964841	HepG2	liver:	n/a	chr4:69964654-69964665 chr4:69964655-69964666 chr4:69964654-69964667
17	CEBPB	chr4:69964211-69964793	A549	lung:	n/a	chr4:69964654-69964665 chr4:69964655-69964666 chr4:69964654-69964667
18	CEBPB	chr4:69932884-69933620	HepG2	liver:	n/a	n/a
19	CEBPB	chr4:69968429-69968717	HepG2	liver:	n/a	n/a
20	CEBPB	chr4:69980567-69980672	HepG2	liver:	n/a	n/a
21	CEBPB	chr4:69961795-69962072	HepG2	liver:	n/a	chr4:69961952-69961965 chr4:69961952-69961963 chr4:69961949-69961966 chr4:69961952-69961965
22	CEBPB	chr4:69962103-69962398	HepG2	liver:	n/a	n/a
23	CEBPB	chr4:69968440-69968803	HepG2	liver:	n/a	n/a
24	CEBPB	chr4:69961159-69961453	A549	lung:	n/a	n/a
25	CEBPB	chr4:69961787-69962551	HepG2	liver:	n/a	chr4:69961952-69961965 chr4:69961952-69961963 chr4:69961949-69961966 chr4:69961952-69961965
26	CEBPB	chr4:69962157-69962338	HepG2	liver:	n/a	n/a
27	CEBPB	chr4:69964243-69964585	HepG2	liver:	n/a	n/a
28	CEBPB	chr4:69961869-69962048	Hela-S3	cervix:	n/a	chr4:69961952-69961965 chr4:69961952-69961963 chr4:69961949-69961966 chr4:69961952-69961965
29	CEBPB	chr4:69964210-69964437	HepG2	liver:	n/a	n/a
30	CEBPB	chr4:69968407-69968710	HepG2	liver:	n/a	n/a
31	CEBPB	chr4:69961861-69962033	HepG2	liver:	n/a	chr4:69961952-69961965 chr4:69961952-69961963 chr4:69961949-69961966 chr4:69961952-69961965
32	CEBPB	chr4:69961802-69962387	A549	lung:	n/a	chr4:69961952-69961965 chr4:69961952-69961963 chr4:69961949-69961966 chr4:69961952-69961965
33	CEBPB	chr4:69932857-69933596	IMR90	lung:	n/a	n/a
34	CEBPB	chr4:69961749-69962164	A549	lung:	n/a	chr4:69961952-69961965 chr4:69961952-69961963 chr4:69961949-69961966 chr4:69961952-69961965
35	CEBPB	chr4:69968322-69968816	HepG2	liver:	n/a	n/a
36	CEBPB	chr4:69961654-69962398	A549	lung:	n/a	chr4:69961952-69961965 chr4:69961952-69961963 chr4:69961949-69961966 chr4:69961952-69961965
37	CEBPB	chr4:69961026-69961496	A549	lung:	n/a	n/a
38	CEBPB	chr4:69960967-69961605	A549	lung:	n/a	n/a
39	CEBPB	chr4:69945882-69946082	HepG2	liver:	n/a	chr4:69945930-69945943 chr4:69945931-69945942
40	CREB1	chr4:69964151-69964530	HepG2	liver:	n/a	n/a
41	CTCF	chr4:69939945-69939997	H1-hESC	embryonic stem cell:	n/a	n/a
42	CTCF	chr4:69938820-69938970	HepG2	liver:	n/a	n/a
43	CTCF	chr4:69954360-69954510	HCT-116	colon:	n/a	n/a
44	CTCF	chr4:69943296-69943316	GM10248	blood:	n/a	n/a
45	CTCF	chr4:69973871-69973986	GM10248	blood:	n/a	n/a
46	CTCF	chr4:69933180-69933330	HRPEpiC	eye:	n/a	n/a
47	CTCF	chr4:69976680-69976830	GM06990	blood:	n/a	n/a
48	CTCF	chr4:69942923-69942962	GM10248	blood:	n/a	n/a
49	CTCF	chr4:69939860-69940010	HepG2	liver:	n/a	n/a
50	CUX1	chr4:69947651-69947676	GM12878	blood:	n/a	n/a

No.	Chromosome Location	Cell Line	Cell type	Cell Stage
1	chr4:69959004-69959054	AG10803	skin:	n/a
2	chr4:69976406-69976456	HNPCEpiC	eye:	n/a
3	chr4:69959004-69959054	H1-hESC	embryonic stem cell:	embryo
4	chr4:69959004-69959054	Hela-S3	cervix:	n/a
5	chr4:69962676-69962726	AG09319	gingival:	n/a
6	chr4:69960869-69960919	HL-60	blood:	n/a
7	chr4:69962676-69962726	HEEpiC	esophagus:	n/a
8	chr4:69976406-69976456	NT2-D1	testis:	n/a
9	chr4:69962676-69962726	Hepatocyte	liver:	n/a
10	chr4:69959004-69959054	GM12891	blood:	n/a
11	chr4:69976406-69976456	BE2_C	brain:	n/a
12	chr4:69959004-69959054	Caco-2	colon:	n/a
13	chr4:69959004-69959054	Hepatocyte	liver:	n/a
14	chr4:69960869-69960919	GM19239	blood:	n/a
15	chr4:69960869-69960919	HRCEpiC	kidney:	n/a
16	chr4:69960869-69960919	A549	lung:	n/a
17	chr4:69959004-69959054	AoSMC	blood vessel:	n/a
18	chr4:69976406-69976456	BJ	skin:	n/a
19	chr4:69976406-69976456	HMEC	breast:	n/a
20	chr4:69959004-69959054	HRCEpiC	kidney:	n/a
21	chr4:69976406-69976456	ovcar-3	ovarian:	n/a
22	chr4:69976406-69976456	MCF-7	breast:	n/a
23	chr4:69959004-69959054	PrEC	prostate:	n/a
24	chr4:69962676-69962726	HepG2	liver:	n/a
25	chr4:69960869-69960919	CMK	blood:	n/a
26	chr4:69962676-69962726	NHBE	bronchial:	n/a
27	chr4:69960869-69960919	HCPEpiC	choroid plexus:	n/a
28	chr4:69962676-69962726	U87	brain:	n/a
29	chr4:69962676-69962726	T-47D	breast:	n/a
30	chr4:69959004-69959054	NHDF-neo	bronchial:	n/a
31	chr4:69960869-69960919	SK-N-MC	brain:	n/a
32	chr4:69960869-69960919	SKMC	muscle:	n/a
33	chr4:69959004-69959054	Jurkat	blood:	n/a
34	chr4:69976406-69976456	NHDF-neo	bronchial:	n/a
35	chr4:69976406-69976456	SK-N-SH_RA	brain:	n/a
36	chr4:69960869-69960919	SAEC	small airway:	n/a
37	chr4:69960869-69960919	NHBE	bronchial:	n/a
38	chr4:69959004-69959054	HEK293	kidney:	embryo
39	chr4:69962676-69962726	GM12892	blood:	n/a
40	chr4:69960869-69960919	Hela-S3	cervix:	n/a
41	chr4:69959004-69959054	HL-60	blood:	n/a
42	chr4:69976406-69976456	HepG2	liver:	n/a
43	chr4:69976406-69976456	NB4	blood:	n/a
44	chr4:69960869-69960919	LNCaP	prostate:	n/a
45	chr4:69959004-69959054	IMR90	lung:	fetal
46	chr4:69976406-69976456	U87	brain:	n/a
47	chr4:69962676-69962726	HUVEC	blood vessel:	n/a
48	chr4:69962676-69962726	BJ	skin:	n/a
49	chr4:69962676-69962726	HEK293	kidney:	embryo
50	chr4:69976406-69976456	AG09309	skin:	n/a

No.	Distal block	Cell Line	Cell type
1	chr4:69964055..69967936-chr4:69969110..69971498,3	K562	blood:
2	chr4:69981403..69984275-chr4:69989733..69991990,2	K562	blood:
3	chr4:69964055..69967936-chr4:69969110..69971498,3	K562	blood:

No.	lncRNA name	Chromosome Location	lncRNA alias
1	lnc-UGT2B28-8	chr4:69933121-69933337	NONHSAT096752
2	lnc-UGT2B28-8	chr4:69935360-69935606	NONHSAT096752

Variant related genes	Relation type
UGT2B7	TF binding region
ENSG00000251284	TF binding region
UGT2B7	CpG island
ENSG00000251284	CpG island
ENSG00000251284	chromatin interactions

Extended variants
information (count: 2421 )
Associated
traits (count: 84 )

Variant overlapped rSNPs/rCNVs (count:2421 , 50 per page) page: 1 2 3 4 5 6 7 ... 49

No.	Variant name	Chromosome position	Chromatin state	Related regulatory elements	Target genes	Extended variants	Associated traits
1	rs9991142	chr4:69932587-69932588	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
2	rs557739716	chr4:69932621-69932622	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
3	rs577614405	chr4:69932672-69932673	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
4	rs186940770	chr4:69932704-69932705	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
5	rs560123957	chr4:69932733-69932734	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
6	rs4434329	chr4:69932752-69932753	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	mRNA abundance
7	rs191691477	chr4:69932756-69932757	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
8	rs377345463	chr4:69932787-69932788	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
9	rs562129880	chr4:69932802-69932803	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
10	rs183098282	chr4:69932810-69932811	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
11	rs557475737	chr4:69932852-69932853	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
12	rs147235633	chr4:69932860-69932861	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
13	rs4259121	chr4:69932870-69932871	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
14	rs533209198	chr4:69932872-69932873	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
15	rs548130225	chr4:69933016-69933017	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
16	rs546471966	chr4:69933047-69933048	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
17	rs372746422	chr4:69933061-69933062	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
18	rs566455547	chr4:69933076-69933077	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
19	rs535241202	chr4:69933077-69933078	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
20	rs548778656	chr4:69933113-69933114	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
21	rs79124783	chr4:69933169-69933170	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
22	rs568781281	chr4:69933173-69933174	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
23	rs117029885	chr4:69933188-69933189	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
24	rs557610572	chr4:69933216-69933217	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
25	rs187741879	chr4:69933221-69933222	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
26	rs533581564	chr4:69933228-69933229	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
27	rs72642961	chr4:69933258-69933259	Weak transcription Enhancers	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
28	rs72851379	chr4:69933265-69933266	Weak transcription Enhancers	lncRNA	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
29	rs542401365	chr4:69933266-69933267	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
30	rs374214780	chr4:69933272-69933273	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
31	rs562268759	chr4:69933285-69933286	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
32	rs191066392	chr4:69933331-69933332	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
33	rs115775173	chr4:69933334-69933335	Weak transcription Enhancers	lncRNA	n/a	Overlapped CNVs	n/a
34	rs182098695	chr4:69933350-69933351	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
35	rs112542213	chr4:69933368-69933369	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
36	rs376504395	chr4:69933369-69933370	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
37	rs62296919	chr4:69933372-69933373	Weak transcription Enhancers	n/a	n/a	LD-proxies of rSNP Overlapped rCNV	n/a
38	rs546608869	chr4:69933378-69933379	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
39	rs559978275	chr4:69933388-69933389	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
40	rs529155990	chr4:69933413-69933414	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
41	rs548915509	chr4:69933441-69933442	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
42	rs569025657	chr4:69933481-69933482	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
43	rs373789280	chr4:69933505-69933506	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
44	rs187767711	chr4:69933506-69933507	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
45	rs551435746	chr4:69933514-69933515	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
46	rs571275705	chr4:69933516-69933517	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
47	rs141590136	chr4:69933537-69933538	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
48	rs114821124	chr4:69933541-69933542	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
49	rs567121708	chr4:69933561-69933562	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a
50	rs536151787	chr4:69933570-69933571	Weak transcription Enhancers	n/a	n/a	Overlapped CNVs	n/a

Variant related diseases (count:84)

Disease	PMID	Source
Gastrointestinal stromal cancer	16982739	CNVD
Acute lymphoblastic leukemia	22237106	CNVD
Glioblastoma multiforme	21080181	CNVD
Esophageal squamous carcinoma	21637470	CNVD
Chordoma	21602918	CNVD
HIV/AIDS	22032296	CNVD
Medulloblastoma	21979893	CNVD
Neuroblastoma	18923191	CNVD
Thoracic aortic aneurysm	21092924	CNVD
Intellectual disability	22102821	CNVD
Autism	22495311	CNVD
Breast cancer	21858162	CNVD
Small bowel adenocarcinoma	21586687	CNVD
Gastric cancer	21586687	CNVD
lymphocytic leukemia	21291569	CNVD
Basal cell lymphoma	16317097	CNVD
Diffuse large b-cell lymphoma	16317097	CNVD
Non-small cell lung cancer	21829676	CNVD
Melanoma	18172304	CNVD
Acute lymphoblastic leukemia	20067559	CNVD
Lung cancer	18438408	CNVD
Breast cancer	17603634	CNVD
Glioblastoma multiforme	21922591	CNVD
Parkinson disease	21956041	CNVD
Mental retardation	20522426	CNVD
delayed speech	20522426	CNVD
growth disorder	20522426	CNVD
Hepatocellular carcinoma	16750200	CNVD
Myxofibrosarcoma	16751306	CNVD
Esophageal squamous carcinoma	18350619	CNVD
Parkinson disease	18923514	CNVD
Non-syndromic sensorineural hearing loss	15273396	CNVD
Cancer	21183584	CNVD
Breast cancer	16272173	CNVD
Multiple myeloma	16616336	CNVD
Colorectal cancer	19359472	CNVD
Malignant mesothelioma	18160781	CNVD
Medulloblastoma	18056178	CNVD
Multiple myeloma	17077331	CNVD
Pleural malignant mesothelioma	18160781	CNVD
Primary mediastinal b-cell lymphoma	17728785	CNVD
Oral squamous cell carcinoma	17134496	CNVD
4q-syndrome	17576883	CNVD
Cancer	21637783	CNVD
Non-syndromic sensorineural hearing loss	18471307	CNVD
Colorectal cancer	20709793	CNVD
Muscular dystrophy	21149563	CNVD
Endometrial cancer	22040021	CNVD
Breast cancer	21264507	CNVD
Glioblastoma multiforme	19960244	CNVD
Glioblastoma multiforme	17387387	CNVD
Hepatocellular carcinoma	22174799	CNVD
Liposarcoma	21253554	CNVD
Oligodendroglial tumors	17285580	CNVD
Cervical cancer	21062161	CNVD
Metanephric adenoma	20802469	CNVD
Breast cancer	16608533	CNVD
Colorectal cancer	16272173	CNVD
Adenoid cystic carcinoma	18698036	CNVD
Lung cancer	19208797	CNVD
Wilms tumour	21544195	CNVD
Breast cancer	21785460	CNVD
Acute myeloid leukemia	21251322	CNVD
Prostate cancer	16573809	CNVD
Osteoporosis	18992858	CNVD
Basal cell lymphoma	17170743	CNVD
Follicular lymphoma	17170743	CNVD
Chronic lymphocytic leukemia	20421269	CNVD
Myelodysplastic syndrome	21251322	CNVD
Multiple myeloma	17550852	CNVD
Graft versus host disease	20877625	CNVD
Breast cancer	21990379	CNVD
Myelofibrosis	22110671	CNVD
Osteoporosis	20877625	CNVD
Osteoporosis	19737800	CNVD
Congenital anomalies of the kidney and urinary tract	18316590	CNVD
Glioblastoma multiforme	21138945	CNVD
T-cell prolymphocytic leukemia	19278963	CNVD
Non-syndromic sensorineural hearing loss	17122850	CNVD
small cell lung cancer	20016488	CNVD
Breast cancer	22522925	CNVD
Non-syndromic sensorineural hearing loss	18451855	CNVD
Non-syndromic sensorineural hearing loss	22037309	CNVD
Pancreatic cancer	17952125	CNVD

Chromatin state (count:220 , 50 per page) page: 1 2 3 4 5

No.	Chromosome Location	Chromatin state	Cell line	Tissue
1	chr4:69925000-69932600	Weak transcription	Foreskin Melanocyte Primary Cells skin01	Skin
2	chr4:69927400-69934400	Weak transcription	Liver	Liver
3	chr4:69930400-69936600	Weak transcription	HepG2	liver
4	chr4:69930600-69932600	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
5	chr4:69930600-69944400	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
6	chr4:69932400-69933000	Enhancers	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
7	chr4:69932400-69933200	Enhancers	hESC Derived CD56+ Mesoderm Cultured Cells	ES cell derived
8	chr4:69932600-69933000	Enhancers	Muscle Satellite Cultured Cells	--
9	chr4:69932600-69933000	Enhancers	Foreskin Keratinocyte Primary Cells skin02	Skin
10	chr4:69932600-69933000	Enhancers	HMEC	breast
11	chr4:69932600-69933000	Enhancers	NHEK	skin
12	chr4:69932600-69933200	Enhancers	HSMM	muscle
13	chr4:69932600-69933400	Enhancers	Foreskin Melanocyte Primary Cells skin01	Skin
14	chr4:69932600-69933600	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
15	chr4:69932800-69933400	Enhancers	Mesenchymal Stem Cell Derived Adipocyte Cultured Cells	ES cell derived
16	chr4:69933600-69936400	Weak transcription	Foreskin Melanocyte Primary Cells skin03	Skin
17	chr4:69934400-69939200	Enhancers	Liver	Liver
18	chr4:69934800-69935000	Enhancers	HMEC	breast
19	chr4:69934800-69935000	Enhancers	NHEK	skin
20	chr4:69936400-69938200	Enhancers	Foreskin Melanocyte Primary Cells skin03	Skin
21	chr4:69936600-69937200	Enhancers	HepG2	liver
22	chr4:69938800-69957400	Weak transcription	Breast variant Human Mammary Epithelial Cells (vHMEC)	Breast
23	chr4:69939200-69939600	Flanking Active TSS	Liver	Liver
24	chr4:69939600-69939800	Enhancers	Liver	Liver
25	chr4:69939800-69940000	Flanking Active TSS	Liver	Liver
26	chr4:69940000-69941200	Enhancers	Liver	Liver
27	chr4:69940800-69941200	Enhancers	Mesenchymal Stem Cell Derived Chondrocyte Cultured Cells	embryonic stem cell
28	chr4:69940800-69941800	Enhancers	Fetal Adrenal Gland	Adrenal Gland
29	chr4:69941000-69941400	Enhancers	Bone Marrow Derived Cultured Mesenchymal Stem Cells	Bone marrow
30	chr4:69941000-69941400	Enhancers	A549	lung
31	chr4:69941000-69941600	Enhancers	Muscle Satellite Cultured Cells	--
32	chr4:69941200-69944400	Weak transcription	Liver	Liver
33	chr4:69944400-69944800	Enhancers	Esophagus	oesophagus
34	chr4:69944400-69945000	ZNF genes & repeats	H1 Derived Mesenchymal Stem Cells	ES cell derived
35	chr4:69944400-69945000	Enhancers	iPS DF 19.11 Cell Line	embryonic stem cell
36	chr4:69944400-69945000	Enhancers	ES-UCSF4 Cell Line	embryonic stem cell
37	chr4:69944400-69945000	Enhancers	Liver	Liver
38	chr4:69944600-69945000	Enhancers	H1 Cell Line	embryonic stem cell
39	chr4:69944600-69945000	Enhancers	iPS DF 6.9 Cell Line	embryonic stem cell
40	chr4:69945000-69957200	Weak transcription	H1 Derived Mesenchymal Stem Cells	ES cell derived
41	chr4:69950800-69951400	Enhancers	iPS-18 Cell Line	embryonic stem cell
42	chr4:69954400-69955000	Enhancers	HepG2	liver
43	chr4:69955000-69955400	Weak transcription	HepG2	liver
44	chr4:69955400-69955600	Enhancers	HepG2	liver
45	chr4:69955600-69959400	Weak transcription	HepG2	liver
46	chr4:69957200-69957800	Genic enhancers	H1 Derived Mesenchymal Stem Cells	ES cell derived
47	chr4:69957400-69957800	Enhancers	Foreskin Fibroblast Primary Cells skin01	Skin
48	chr4:69957400-69958000	Enhancers	Muscle Satellite Cultured Cells	--
49	chr4:69957400-69958000	Enhancers	HSMM	muscle
50	chr4:69957400-69958000	Enhancers	HSMMtube	muscle

The 2.0 version of rSNPBase

Variant report

Quick Search:

what's new

Quick links